Literature DB >> 28426142

Integrated care in cancer: What is it, how is it used and where are the gaps? A textual narrative literature synthesis.

L J Cortis1, P R Ward2, R A McKinnon1, B Koczwara1.   

Abstract

Integrated care is an underpinning concept of contemporary health care policy proffered as a strategy to overcome the fragmentations in care encountered by people with complex care needs (Shaw et al. [2011] What is Integrated Care? An Overview of Integrated Care in the NHS). Cancer patients have potential to benefit from such policy, often having needs that extend beyond cancer. This paper seeks to understand how the concept of integrated care is used in the cancer literature. A search of leading databases was conducted for original research relating to integrated care or an integration intervention aiming to improve outcomes of cancer patients, and analysed using textual narrative synthesis. 38 papers were included, each with a focus on improving cancer-specific aspects of care enhancing the capabilities of the cancer multidisciplinary team. Of the eight studies involving integration between the cancer service and other care providers, all focused on utilising the external provider to deliver aspects of cancer care or placed them in a passive role, as survey participant, a recipient of cancer-related clinical information or as the comparator "usual care" arm. Within the cancer literature, integration is predominantly used to describe initiatives to improve cancer-related aspects of care. Less attention is given to integration initiatives that enhance coordination across levels of the healthcare system or service providers.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; health policy; health service delivery; integrated care

Mesh:

Year:  2017        PMID: 28426142     DOI: 10.1111/ecc.12689

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Cross Disciplinary Role Agreement is Needed When Coordinating Long-Term Opioid Prescribing for Cancer: a Qualitative Study.

Authors:  K F Giannitrapani; M J Silveira; A Azarfar; P A Glassman; S J Singer; S M Asch; A M Midboe; M A Zenoni; R C Gamboa; W C Becker; K A Lorenz
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

2.  Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care.

Authors:  Amy L Clarke; Julia Roscoe; Rebecca Appleton; Deepak Parashar; Radha Muthuswamy; Omar Khan; Jeremy Dale; Veronica Nanton
Journal:  Support Care Cancer       Date:  2019-07-23       Impact factor: 3.603

3.  In Limbo: Seven Families' Experiences of Encounter with Cancer Care in Norway.

Authors:  Monica Solberg; Geir Vegard Berg; Hege Kristin Andreassen
Journal:  Int J Integr Care       Date:  2021-11-26       Impact factor: 5.120

4.  Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk.

Authors:  Samantha B Meyer; Belinda Lunnay; Megan Warin; Kristen Foley; Ian N Olver; Carlene Wilson; Sara Macdonald S; Paul R Ward
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

5.  Factors associated with healthcare utilisation during first year after cancer diagnose-a population-based study.

Authors:  Helena Ullgren; Lena Sharp; Anna Olofsson; Per Fransson
Journal:  Eur J Cancer Care (Engl)       Date:  2020-11-20       Impact factor: 2.520

6.  Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors.

Authors:  Jennifer Hunter; Jane Ussher; Chloe Parton; Andrew Kellett; Caroline Smith; Geoff Delaney; Eleanor Oyston
Journal:  BMC Complement Altern Med       Date:  2018-05-09       Impact factor: 3.659

7.  Providing person-centered care for patients with complex healthcare needs: A qualitative study.

Authors:  Vincent J T Peters; Bert R Meijboom; Jan Erik H Bunt; Levinus A Bok; Marianne W van Steenbergen; J Peter de Winter; Esther de Vries
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.